Woods, Laura M.
Ali, Fahad R.
Gomez, Roshna
Chernukhin, Igor
Marcos, Daniel
Parkinson, Lydia M.
Tayoun, Ahmad N. Abou
Carroll, Jason S.
Philpott, Anna
Funding for this research was provided by:
Cancer Research UK (A25636, A20411 and A31344)
Cancer Research UK (A25636, A20411 and A31344)
Cancer Research UK (A25636, A20411 and A31344)
Cancer Research UK (A25636, A20411 and A31344)
Cancer Research UK (A25636, A20411 and A31344)
Cancer Research UK (A25636, A20411 and A31344)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z)
Medical Research Council (MC_PC_17230)
Medical Research Council (MC_PC_17230)
Medical Research Council (MC_PC_17230)
Medical Research Council (MC_PC_17230)
Medical Research Council (MC_PC_17230)
MBRU ALMAHMEED Collaborative Research Award ALM1909 (ALM)
MBRU ALMAHMEED Collaborative Research Award ALM1909 (ALM)
MBRU College of Medicine Internal grant award (MBRU-CM-RG2019–14)
MBRU College of Medicine Internal grant award (MBRU-CM-RG2019–14)
MBRU College of Medicine Internal grant award (MBRU-CM-RG2019–14)
Neuroblastoma UK
Article History
Received: 1 October 2021
Accepted: 23 March 2022
First Online: 3 April 2022
Declarations
:
: This study uses a long-established cell line that is freely available and there are no issue of consent or ethics approvals required that we are aware of.
: Not applicable.
: The authors declare that they have no competing interests.